Nevakar Inc.
PrivateLast Round
Convertible Debt
Mar 9, 2022
Total Funding Raised
$99.5M
Company Overview
Nevakar Inc. operates in Healthcare & Life Sciences and is based in Bridgewater, New Jersey. Its latest recorded funding round was a Convertible Debt round in March 2022.
Nevakar Inc. is a biopharmaceutical company that develops and commercializes innovative products for the ophthalmic and injectable areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nevakar Inc. Comparables
Compare Nevakar Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rhoshan Pharmaceuticals, Inc. | 78% | |
| Hyloris Pharmaceuticals | 76% | |
| Pfizer | 73% |
For institutional investors. Book with your work email.
Nevakar Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 9, 2022 | ||||
| Debt | Oct 7, 2019 | ||||
| Debt | Jun 18, 2019 | ||||
| Debt | Nov 29, 2018 | ||||
| VC Round | Jul 27, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nevakar Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NovaQuest Capital Management | Debt |
| Oxford Finance | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 212% MoM, reaching 2.6K.
- Jun 1, 2025
Monthly visitors increased 80% MoM.
For institutional investors. Book with your work email.
Nevakar Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nevakar Inc.'s valuation, stock price, and market status.
Is Nevakar Inc. a public or private company?
Nevakar Inc. is a private company.
What is the current stock price of Nevakar Inc.?
Nevakar Inc. is a private company, so its shares have no public market price. Caplight tracks Nevakar Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nevakar Inc. worth (valuation)?
Valuation information for Nevakar Inc. is not publicly available.
Can I buy Nevakar Inc. stock?
Nevakar Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nevakar Inc.'s last funding round?
Nevakar Inc.'s most recent funding round was Convertible Debt on March 9, 2022.
Who are the main investors in Nevakar Inc.?
Key investors in Nevakar Inc. include NovaQuest Capital Management, Oxford Finance.
Will Nevakar Inc. IPO soon?
No public IPO plans have been announced for Nevakar Inc..
How can I track Nevakar Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nevakar Inc.'s shares on secondary markets.